Menu

VBI Vaccines Inc. VBIV

Full chart Compare
Set alert

Price alert · VBIV

All alert types
0.07 USD 0.00 (+0.00%)

At closeAug 7, 2024, 4:00 PM EDT

0.0574 Day range 0.0866
0.0132 52-week range 1.35

Revenue & Expenses

Net Loss → Expenses: $92.84MExpenses → Gross Loss: $3.83MExpenses → Selling, General & Admin: $42.14MExpenses → Research & Development: $9.34MExpenses → Other Operating Expenses: $24.60MExpenses → Interest Expense: $6.40MExpenses → Other Expenses: $6.52MRevenue → Cost of Revenue: $8.68MNet Loss$92.84MCost of Revenue$12.51MExpenses$92.84MGross Loss$3.83MSelling, General & Admin$42.14MResearch & Development$9.34MOther Operating Expenses$24.60MInterest Expense$6.40MOther Expenses$6.52MRevenue$8.68M

Latest period ending Dec 31, 2023 · select a line to chart its full history

VBIV annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
8.68M1.08M631.00K1.06M2.22M
-3.83M-10.19M-10.14M-8.11M-5.68M
-79.91M-81.82M-68.03M-43.62M-52.40M
-92.84M-113.30M-69.75M-46.23M-54.81M
-6.03-13.16-8.10-6.30-13.80
VBIV annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
23.68M62.63M121.69M93.83M44.21M
86.95M155.09M210.28M209.37M122.20M
79.42M90.92M66.39M37.67M33.95M
53.04M52.23M31.80M17.89M16.30M
7.53M64.16M143.88M171.71M88.25M
VBIV annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-60.88M-73.69M-39.91M-47.05M-48.71M
-867.00K-4.34M23.16M-26.00M-3.67M
22.70M19.45M44.29M122.39M37.41M
-867.00K-4.34M-2.00M-1.00M-3.67M
-38.94M-59.06M27.87M-49.61M-15.06M